Colon Cancer and Bile Acids Study Notes

Introduction to Colon Cancer and Bile Acids

  • Overview of the impact of bile acids on colorectal cancer (CRC).

Secondary Bile Acids and Colorectal Cancer Risk

  • Secondary bile acids are major risk factors in CRC.

  • Both primary and secondary bile acids play crucial roles in cancer promotion.

Chemical Structure of Bile Acids

  • Primary Bile Acids: Compounds synthesized from cholesterol in the liver.

    • Examples:

    • Chenodeoxycholic acid

    • Cholic acid

  • Secondary Bile Acids: Formed through the biotransformation of primary bile acids by intestinal bacteria.

    • Examples:

    • Deoxycholic acid (DCA)

    • Lithocholic acid

Metabolism and Circulation of Bile Acids

  • Bile acids are synthesized in the liver, stored in the gall bladder, and released into the intestine.

  • Enterohepatic circulation involves:

    • Resorption of bile acids in the terminal ileum.

    • Excretion typically at rates of (0.3-0.5 ext{ g}) per day.

Mechanisms of DCA Promoting Cancer

  • Inflammatory Pathway Activation:

    • DCA promotes inflammation, which may lead to cancer through the activation of:

    • Cyclooxygenase-2 (COX-2)

    • Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kB)

  • Impact on Eicosanoid Pathway:

    • DCA influences various eicosanoids, which have either pro-inflammatory or anti-inflammatory properties.

    • Examples of eicosanoids include:

    • Prostaglandins (PGs)

    • Thromboxanes (TXs)

    • Leukotrienes (LTs)

Relationship of Omega Fatty Acids to Inflammation

  • Omega-3 Fatty Acids: Less inflammatory, include:

    • Alpha-linolenic acid (ALA): (18:3 ext{ w-3})

    • Eicosapentaenoic acid (EPA): (20:5 ext{ w-3})

    • Docosahexaenoic acid (DHA): (22:6 ext{ w-3})

  • Omega-6 Fatty Acids: More inflammatory, include:

    • Arachidonic acid (AA): (20:4 ext{ w-6})

DCA's Mechanism of Action and Impact on Cells

  • DCA activates COX-2, leading to an increase in inflammatory cytokines such as IL-1β and TNF-α, promoting tumor promotion.

  • Process Summary:

    • DCA increases:

    • Cell proliferation

    • Inflammation

    • DCA decreases:

    • Apoptosis (programmed cell death)

    • Promotes mutations in critical genes such as APC and p53, leading to malignancy.

Effects of DCA: Dose and Duration

  • Low Doses:

    • Promote cancer progression.

  • High Doses:

    • Induce apoptosis.

  • Chronic High Doses:

    • Lead to:

    • Resistance to apoptosis

    • Continued genetic mutations and tumor formation.

Strategies to Reduce DCA Effects in the Colon

  • Dietary Interventions:

    • Adopting a low-fat diet.

    • Increasing fiber intake.

    • Incorporating Conjugated Linoleic Acid (CLA).

    • Omega-3 fatty acids.

    • Aspirin use.

High Fiber Diet Effects

  • Mechanism of Action:

    • Indigestible fibers ferment in the colon.

  • Types of Fiber:

    • Soluble Fiber:

    • Ferments well, producing short-chain fatty acids (SCFAs) such as acetate, propionate, butyrate, which are anti-inflammatory.

    • Helps lower colonic pH, inhibiting conversion of primary bile acids into harmful secondary bile acids like DCA.

    • Sources include: legumes, avocado, broccoli, brussels sprouts, onions, and sweet potatoes.

    • Insoluble Fiber:

    • Low fermentation, poor SCFA producers.

    • Binds to bile acids, especially at low pH.

    • Examples: wheat bran, oats, and oat bran.

Role of Conjugated Linoleic Acid

  • Mimics actions of tumor suppressor genes such as p53.

  • Causes G1/S arrest in the cell cycle, resulting in reduced cell growth.

  • Food sources include beef and dairy, especially goat cheese.

Omega-3 Fatty Acids and Aspirin Role in Reducing DCA Effects

  • Both shown to mitigate the inflammatory response and potentially reduce tumor promotion through their effects on the eicosanoid pathway.

Drugs Targeting Eicosanoid Production

  • Celebrex:

    • A COX-II inhibitor used in arthritis treatment, reducing the production of inflammatory prostaglandins derived from arachidonic acid.

  • Zileuton:

    • Inhibits 5-lipoxygenase (5-LO), a target for asthma medications, reducing leukotriene synthesis and related inflammation.

  • Aspirin and Ibuprofen:

    • Act as non-selective COX inhibitors, reducing pain, swelling, and inflammation by limiting the production of prostaglandins.

  • Inflammation-related Cytokines:

    • Pro-inflammatory cytokines such as TNF-α and IL-1β contribute to inflammation, and antagonists targeting these cytokines may aid in managing inflammation-related conditions.